Praxsyn (Praxsyn) Land And Improvements : $0.00 Mil (As of Sep. 2015)

View and export this data going back to 2007. Start your Free Trial

What is Praxsyn Land And Improvements?

Praxsyn's land and improvements for the quarter that ended in Sep. 2015 was $0.00 Mil.

Praxsyn Land And Improvements Historical Data

The historical data trend for Praxsyn's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Praxsyn Land And Improvements Chart

Praxsyn Annual Data

Trend

Oct05

Oct06

Oct07

Oct08

Oct09

Dec10

Dec11

Dec12

Dec13

Dec14

Land And Improvements

Get a 7-Day Free Trial

Praxsyn Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Land And Improvements	Get a 7-Day Free Trial															-	-	-	-	-

Praxsyn Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Praxsyn (Praxsyn) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Praxsyn Corp (GREY:PXYN) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

61 Spectrum Boulevard, Suite A, Las Vegas, NV, USA, 89101

Website

http://www.praxsyncorp.com

Praxsyn Corp is a healthcare company, dedicated to providing medical practitioners with medications and services for their patients. Through its retail pharmacy facility, it formulates healthcare practitioner-prescribed medications to serve patients who experience chronic pain. It primarily focuses on non-narcotic and non-habit forming medications using therapeutic and preventative agents for pain management. In addition, the group prepares innovative products that address erectile dysfunction and metabolic issues and other ancillary products. The products of the firm are either picked up directly from pharmacy facility or shipped directly to patients. The business activities are functioned through the regions of United States.